Brought to you by 
Ferring gets rights to BioSET's orthobiologic assets
23 Jun 2022
Executive Summary
Ferring Pharmaceuticals AS acquired rights from BioSurface Engineering Technologies Inc. (BioSET) to assets designed to improve bone health, including Phase III-ready orthobiologics Amplex and Prefix.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ferring gets rights to BioSET's orthobiologic assets
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice